Epigenetic regulation of prostate cancer

Ruixin Wang; Xiaoqi Liu

doi:10.1016/j.gendis.2019.10.018

您当前的位置：

首页 >

文章列表页 >

Epigenetic regulation of prostate cancer

Review article | 更新时间：2022-06-24

- Epigenetic regulation of prostate cancer
- Epigenetic regulation of prostate cancer
- Genes & Diseases 2020年7卷第4期
- 作者机构：
  
  1. Department of Biochemistry, Purdue University, West Lafayette,IN,USA,47907
  2. Department of Toxicology and Cancer Biology, University of Kentucky,KY,Lexington,USA,40536
  3. Markey Cancer Center, University of Kentucky,KY,Lexington,USA,40536
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2019.10.018
  中图分类号：
- 纸质出版日期：2020，
  
  网络出版日期：2020-12-1，
扫描看全文
Ruixin Wang, Xiaoqi Liu. Epigenetic regulation of prostate cancer[J]. Genes & Diseases, 2020,7(4).

Ruixin Wang, Xiaoqi Liu. Epigenetic regulation of prostate cancer[J]. Genes & Diseases, 2020,7(4).
Ruixin Wang, Xiaoqi Liu. Epigenetic regulation of prostate cancer[J]. Genes & Diseases, 2020,7(4). DOI： 10.1016/j.gendis.2019.10.018.

Ruixin Wang, Xiaoqi Liu. Epigenetic regulation of prostate cancer[J]. Genes & Diseases, 2020,7(4). DOI： 10.1016/j.gendis.2019.10.018.

摘要

Abstract

Prostate cancer is (PCa) the second leading cause of cancer death in males in the United State

with 174

650 new cases and 31

620 deaths estimated in 2019. It has been documented that epigenetic deregulation such as histone modification and DNA methylation contributes to PCa initiation and progression. EZH2 (enhancer of zeste homolog 2)

the catalytic subunit of the Polycomb Repressive Complex (PRC2) responsible for H3K27me3 and gene repression

has been identified as a promising target in PCa. In addition

overexpression of other epigenetic regulators such as DNA methyltransferases (DNMT) is also observed in PCa. These epigenetic regulators undergo extensive post-translational modifications

in particular

phosphorylation. AKT

CDKs

PLK1

PKA

ATR and DNA-PK are the established kinases responsible for phosphorylation of various epigenetic regulators.

关键词

Keywords

DNMTEpigeneticsEZH2HDACPhosphorylationProstate cancer

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Nicotinamide N-methyltransferase and liver diseases

Antagonizing exosomal miR-18a-5p derived from prostate cancer cells ameliorates metastasis-induced osteoblastic lesions by targeting Hist1h2bc and activating Wnt/β-catenin pathway

Hydrogen sulfide-induced post-translational modification as a potential drug target

Targeting p85β nuclear translocation for the tumors with PIK3CA helical domain mutations

Reversible N6-methyladenosine of RNA: The regulatory mechanisms on gene expression and implications in physiology and pathology